Elkiran Ozlem, Akdeniz Celal, Karacan Mehmet, Tuzcu Volkan
Department of Pediatric Cardiology, Faculty of Medicine, Inonu University, Malatya, Turkey.
Department of Pediatric Cardiology/Electrophysiology, Istanbul Medipol University Hospital, Istanbul, Turkey.
Pacing Clin Electrophysiol. 2019 Apr;42(4):453-457. doi: 10.1111/pace.13619. Epub 2019 Feb 21.
Atrial tachycardia (AT) is an uncommon cause of supraventricular tachycardia in children and it is often resistant to medical therapy. Catheter ablation can be curative in children with AT. However, experience of ablation of pediatric AT is still very limited. The aim of this study, which is the largest series from a single center, was to assess the efficacy and safety of ablation of AT using an electroanatomical-mapping system.
It was a retrospective review of 39 children with AT who underwent catheter ablation procedure using the EnSite Velocity system (St. Jude Medical, St. Paul, MN, USA) between July 2012 and April 2017.
The mean patient age was 13.32 ± 6.82 years. The location of AT was right sided in 25 and left sided in 13, and both sides in one patient. The mean procedure time was 184.23 ± 60.19 min. Fluoroscopy was not used in 25 of 39 patients. The mean fluoroscopy time in the remaining patients was 5.53 ± 5.22 min. Radiofrequency (RF) ablation was used in 22, cryoablation was used in 10, and both RF and cryoablation were used in seven. Acute success was achieved in 34 patients (87.2%). During a mean follow-up of 51.35 ± 12.62 months, AT recurred in five patients. These patients underwent second ablation procedures and four of them were successful. Final success was achieved in 33 out of 39 patients (84.6%). There were no complications except for one patient who had an uneventful pericardial needle injury during transseptal puncture without effusion.
Catheter ablation of AT in children can be performed safely and effectively with a limited fluoroscopy using electroanatomical mapping systems.
房性心动过速(AT)是儿童室上性心动过速的一种罕见病因,且常常对药物治疗耐药。导管消融对患有AT的儿童可能具有治愈效果。然而,儿科AT消融的经验仍然非常有限。本研究是来自单一中心的最大系列研究,旨在评估使用电解剖标测系统消融AT的有效性和安全性。
这是一项对39例接受导管消融手术的AT患儿的回顾性研究,这些患儿于2012年7月至2017年4月期间使用EnSite Velocity系统(美国明尼苏达州圣保罗市圣犹达医疗公司)进行了手术。
患者的平均年龄为13.32±6.82岁。AT位于右侧的有25例,位于左侧的有13例,1例双侧均有。平均手术时间为184.23±60.19分钟。39例患者中有25例未使用荧光透视。其余患者的平均荧光透视时间为5.53±5.22分钟。22例使用了射频(RF)消融,10例使用了冷冻消融,7例同时使用了RF和冷冻消融。34例患者(87.2%)获得急性成功。在平均51.35±12.62个月的随访期间,5例患者AT复发。这些患者接受了第二次消融手术,其中4例成功。39例患者中有33例(84.6%)最终成功。除1例患者在经房间隔穿刺时发生心包针损伤且无积液外,无其他并发症。
使用电解剖标测系统,在有限的荧光透视下,对儿童AT进行导管消融可安全有效地进行。